• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

WHO | Meningococcal disease in Nigeria (Situation Updates)

Giuseppe

Emeritus
WHO | Meningococcal disease in Nigeria

Meningococcal disease in Nigeria

19 February 2009 --

As of 8 February 2009, the Ministry of Health of the Federal Republic of Nigeria has reported 1364 suspected cases of meningococcal disease including 108 deaths (case-fatality rate: 7.9%) in 19 out of 35 states and Abuja.


So far 30 Local Government Areas (LGA) in 8 states have crossed the alert or the epidemic threshold. In the last week, 11 LGAs crossed the epidemic threshold, and 600 suspected cases including 40 deaths were reported across the country.

Cerebrospinal fluid specimens collected from Jigawa state have tested positive for Neisseria meningitidis serogroup A by latex test.

The International Coordinating Group (ICG) on Vaccine Provision for Epidemic Meningitis Control has approved the release of 268 750 doses of polysaccharide vaccine for a mass vaccination campaign in two affected LGAs in Jigawa state.

WHO is supporting the Federal and National Ministry of Health in the submission of additional requests to the ICG to secure vaccine for the remaining affected areas.

WHO is supporting the Ministry of Health to strengthen epidemiological and laboratory surveillance and data management.
-
<cite cite="http://www.who.int/csr/don/2009_02_19/en/index.html">WHO | Meningococcal disease in Nigeria</cite>
 
Re: WHO | Meningococcal disease in Nigeria (2/19/2009)

Re: WHO | Meningococcal disease in Nigeria (2/19/2009)

WHO | Meningococcal disease in Nigeria - update

Meningococcal disease in Nigeria - update

4 March 2009 --

The Ministry of Health of the Federal Republic of Nigeria has reported 5 323 suspected cases of meningococcal disease including 333 deaths (case-fatality rate: 6.3%) from 1 January to 22 February 2009.


Suspected cases have been reported from 22 of 37 states.

So far 89 Local Government Area's (LGA) across 12 states have crossed the alert or the epidemic threshold.

In the last week alone, 1 817 suspected cases including 105 deaths (case-fatality rate: 5.8%) have been reported, with 28 LGAS crossing the epidemic threshold, and 29 the alert threshold.

Cerebrospinal fluid specimens collected from Gombe, Jigawa, Kano and Katsina states have tested positive for Neisseria meningitidis serogroup A by latex test and/or culture. The International Coordinating Group (ICG) on Vaccine Provision for Epidemic Meningitis Control has approved the release of 1,010,000 doses of polysaccharide vaccine for mass vaccination campaigns in affected LGAs of Jigawa and Katsina states.

Immunization campaigns will be implemented by Federal and National Ministry of Health with the support of WHO and partners, including the European Commission Humanitarian Aid Department (ECHO), M?decins sans Fronti?res and UNICEF.

Given the large population at risk, the early start of epidemics, and current moderate global vaccine levels, a sound vaccination strategy is of particular importance.

WHO is supporting the Federal and National Ministry of Health in the assessment of vaccine needs. WHO is also providing technical and material support to the Ministry of Health to strengthen epidemiological and laboratory surveillance, including provision of laboratory confirmation supplies.
-
<cite cite="http://www.who.int/csr/don/2009_03_04/en/index.html">WHO | Meningococcal disease in Nigeria - update</cite>
 
Back
Top Bottom